Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/18335328
Conclusion of this study
Myo-inositol administration improves reproductive axis functioning in PCOS patients reducing the hyperinsulinemic state that affects LH secretion.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study